The global market for anti-infective vaccines is entering a period of robust growth, driven by mounting infectious-disease burden, rising immunisation awareness and accelerating vaccine platform ...
Most teams set a single percentage threshold across the board that’s simple but flawed. A 5% swing in a volatile revenue account might mean nothing, while a 2% movement in an accrued liabilities could ...
Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback